These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 16681060)

  • 1. The efficacy of unoprostone isopropyl as an adjunct to topical beta-blocker in patients with open angle glaucoma: a-6-month study.
    Leelachaikul Y; Euswas A
    J Med Assoc Thai; 2005 Nov; 88 Suppl 9():S100-4. PubMed ID: 16681060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of unoprostone isopropyl 0.12% and timolol maleate 0.5% on diurnal intraocular pressure.
    Stewart WC; Stewart JA; Kapik BM
    J Glaucoma; 1998 Dec; 7(6):388-94. PubMed ID: 9871860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraocular pressure-lowering efficacy of latanoprost in patients with normal-tension glaucoma or primary open-angle glaucoma.
    Tamada Y; Taniguchi T; Murase H; Yamamoto T; Kitazawa Y
    J Ocul Pharmacol Ther; 2001 Feb; 17(1):19-25. PubMed ID: 11322634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-masked randomized comparison of the efficacy and safety of unoprostone with timolol and betaxolol in patients with primary open-angle glaucoma including pseudoexfoliation glaucoma or ocular hypertension. 6 month data.
    Nordmann JP; Mertz B; Yannoulis NC; Schwenninger C; Kapik B; Shams N;
    Am J Ophthalmol; 2002 Jan; 133(1):1-10. PubMed ID: 11755834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long-term efficacy and safety of combined topical antiglaucoma therapy--timolol & unoprostone vs. betaxolol & unoprostone].
    Ohtake Y; Tanino T; Kimura I; Mashima Y; Oguchi Y
    Nippon Ganka Gakkai Zasshi; 2004 Jan; 108(1):23-8. PubMed ID: 14969090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the intraocular pressure-lowering effect of 0.5% timolol maleate and the docosanoid derivative of a PGF2 alpha metabolite, 0.12% unoprostone, in subjects with chronic open-angle glaucoma or ocular hypertension.
    Nordmann JP; Rouland JF; Mertz BP
    Curr Med Res Opin; 1999; 15(2):87-93. PubMed ID: 10494491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of different dose schedules of 0.15% unoprostone isopropyl on intraocular pressure and pupil size in the glaucomatous beagle.
    Gelatt KN; Mackay EO; Dashiell T; Biken A
    J Ocul Pharmacol Ther; 2004 Oct; 20(5):411-20. PubMed ID: 15650516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evaluation of UF-021 (Rescula; isopropyl unoprostone).
    Yamamoto T; Kitazawa Y; Azuma I; Masuda K
    Surv Ophthalmol; 1997 Feb; 41 Suppl 2():S99-103. PubMed ID: 9154284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of latanoprost and unoprostone when used alone or in combination for open-angle glaucoma.
    Saito M; Takano R; Shirato S
    Am J Ophthalmol; 2001 Oct; 132(4):485-9. PubMed ID: 11589867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The safety and efficacy of unoprostone 0.15% versus brimonidine 0.2%.
    Stewart WC; Stewart JA; Day DG; Jenkins J
    Acta Ophthalmol Scand; 2004 Apr; 82(2):161-5. PubMed ID: 15043534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brimonidine 0.2% vs unoprostone 0.15% both added to timolol maleate 0.5% given twice daily to patients with primary open-angle glaucoma or ocular hypertension.
    Sharpe ED; Henry CJ; Mundorf TK; Day DG; Stewart JA; Jenkins JN; Stewart WC
    Eye (Lond); 2005 Jan; 19(1):35-40. PubMed ID: 15094733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increase in outflow facility with unoprostone treatment in ocular hypertensive patients.
    Toris CB; Zhan G; Camras CB
    Arch Ophthalmol; 2004 Dec; 122(12):1782-7. PubMed ID: 15596580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraocular pressure-lowering effects of latanoprost monotherapy versus latanoprost or pilocarpine in combination with timolol: a randomized, observer-masked multicenter study in patients with open-angle glaucoma. Italian Latanoprost Study Group.
    Bucci MG
    J Glaucoma; 1999 Feb; 8(1):24-30. PubMed ID: 10084271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase 2, randomized, dose-response trial of taprenepag isopropyl (PF-04217329) versus latanoprost 0.005% in open-angle glaucoma and ocular hypertension.
    Schachar RA; Raber S; Courtney R; Zhang M
    Curr Eye Res; 2011 Sep; 36(9):809-17. PubMed ID: 21851167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of bimatoprost and unoprostone isopropyl on the intraocular pressure of normal cats.
    Bartoe JT; Davidson HJ; Horton MT; Jung Y; Brightman AH
    Vet Ophthalmol; 2005; 8(4):247-52. PubMed ID: 16008704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of topical unoprostone isopropyl on optic nerve head circulation in controls and in normal-tension glaucoma patients.
    Kimura I; Shinoda K; Tanino T; Ohtake Y; Mashima Y
    Jpn J Ophthalmol; 2005; 49(4):287-93. PubMed ID: 16075327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraocular pressure fluctuations in response to the water-drinking provocative test in patients using latanoprost versus unoprostone.
    Susanna R; Medeiros FA; Vessani RM; Giampani J; Borges AS; Jordão ML
    J Ocul Pharmacol Ther; 2004 Oct; 20(5):401-10. PubMed ID: 15650515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Additive efficacy of unoprostone isopropyl 0.12% (rescula) to latanoprost 0.005%.
    Stewart WC; Sharpe ED; Stewart JA; Holmes KT; Latham KE
    Am J Ophthalmol; 2001 Mar; 131(3):339-44. PubMed ID: 11239866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Switching to latanoprost monotherapy for 24 weeks in glaucoma patients.
    Takahashi I; Tanaka M
    Eur J Ophthalmol; 2004; 14(5):401-6. PubMed ID: 15506602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical evaluation of isopropyl unoprostone (Rescula), in the adjunctive treatment of primary open angle glaucoma].
    Zarnowski T; Kawa P; Jurkowska-Dudzińska J; Zagórski Z
    Klin Oczna; 2001; 103(1):13-5. PubMed ID: 11605578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.